Modulari-T
We teach your immune system to attack and cure cancer
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering. Modulari-T is a Y Combinator company (Winter 2023). YC-listed status: Active.
- Website
- modularit.bio
- Location
- Montreal, QC, Canada; San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Modulari-T — Biotech platform developing next-generation modular immune receptors and in vivo gene delivery vehicles to overcome CAR-T therapy limitations. · Other
Links
- Y Combinator profileycombinator